Figure 1 shows the workflow for the identification of BRCA1/2 pathogenic mutations in the current study. The Figure 1 illustrates that BRCA mutations appeared in serous and endometrioid carcinomas but not in mucinous and clear cell carcinomas. Here, BRCA1 is linked to clear cell adenocarcinoma.